Case Reports in Infectious Diseases

Case Reports in Infectious Diseases / 2019 / Article

Corrigendum | Open Access

Volume 2019 |Article ID 8314349 | https://doi.org/10.1155/2019/8314349

Erik Skoglund, Henrietta Abodakpi, Rafael Rios, Lorena Diaz, Elsa De La Cadena, An Q. Dinh, Javier Ardila, William R. Miller, Jose M. Munita, Cesar A. Arias, Vincent H. Tam, Truc T. Tran, "Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways”", Case Reports in Infectious Diseases, vol. 2019, Article ID 8314349, 1 page, 2019. https://doi.org/10.1155/2019/8314349

Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways”

Received04 Mar 2019
Accepted12 Mar 2019
Published02 Sep 2019

In the article titled “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways” [1], a grant number was missing. The Acknowledgments section should be updated as follows.

We thank Morouge Alramadhan for technical support. We also thank the Universidad El Bosque for financial support for whole genome sequencing (Grant no. PCI-2017-9447). This work was supported by the National Institutes of Health (Grant nos. K08-AI113317 (TTT) and K24-AI121296 (CAA)), the Millennium Science Initiative of the Ministry of Economy, Development and Tourism, Government of Chile (JMM), and the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), FONDECYT 1171805, Ministry of Education, Government of Chile (JMM).

References

  1. E. Skoglund, H. Abodakpi, R. Rios et al., “In Vivo resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa arising by ampC- and non-ampC-mediated Pathways,” Case Reports in Infectious Diseases, vol. 2018, Article ID 9095203, 4 pages, 2018. View at: Publisher Site | Google Scholar

Copyright © 2019 Erik Skoglund et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views370
Downloads253
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.